drugset / Trial / NCT01863199
Impact of Home Monitoring to Decrease the Treatment Burden for Neovascular Age-related Macular Degeneration (AMD)
RandomizedParallel-groupOpen-labelTreatment
Summary
A study to use in home technology to reduce the burden of in office visits and injections.
Timeline
- Start
- 2013-05
- Primary completion
- 2015-11
- Completion
- 2015-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ranibizumab | Monoclonal antibody | 0.5 mg | Intravitreal |